CNCR vs. INDF

Last updated Jun 3, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and INDF (Nifty India Financials ETF) are both exchange-traded funds - CNCR is a Health & Biotech Equities fund tracking the Loncar Cancer Immunotherapy Index, while INDF is a Financials Equities fund tracking the Nifty Financial Services 25/50 Index. Both are passively managed. CNCR charges 0.79%/yr vs 0.75%/yr for INDF.

Performance

CNCR vs. INDF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and Nifty India Financials ETF (INDF). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

INDF

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. INDF - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
INDF Nifty India Financials ETF	0.00%

CNCR vs. INDF - Sectors Allocation Comparison

Sectors	CNCR	INDF
Healthcare	96.6%	-
Financial Services	3.3%	100.0%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

CNCR vs. INDF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and Nifty India Financials ETF (INDF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Drawdowns

Drawdown Indicators

	CNCR	INDF	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	—	—
Current Drawdown Current decline from peak	0.00%	—	—
Average Drawdown Average peak-to-trough decline	0.00%	—	—

Volatility

Volatility by Period

	CNCR	INDF	Difference
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	—	—

CNCR vs. INDF - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is higher than INDF's 0.75% expense ratio.

Dividends

CNCR vs. INDF - Dividend Comparison

CNCR has not paid dividends to shareholders, while INDF's dividend yield for the trailing twelve months is around 21.29%.

Position	TTM	2025	2024	2023	2022	2021
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
INDF Nifty India Financials ETF	21.29%	21.29%	6.15%	8.84%	3.12%	1.58%

Frequently Asked Questions

Which ETF is better, CNCR or INDF?

On fees, INDF is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or INDF?

INDF is cheaper with a 0.75% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, CNCR or INDF?

INDF has the higher dividend yield at 21.29%, compared with 0.00% for CNCR.

What is the main difference between CNCR and INDF?

CNCR is categorized as Health & Biotech Equities, while INDF is Financials Equities. CNCR tracks Loncar Cancer Immunotherapy Index, while INDF tracks Nifty Financial Services 25/50 Index. Their fees differ too: 0.79% for CNCR and 0.75% for INDF.